dr bennett's semaglutide FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Tirzepatide vs. Semaglutide: What's the

ReisCEDreaJGDa CostaTH

Researchers found that the GLP-1 group did not have higher rates of gestational diabetes, severe maternal morbidity, or other adverse maternal outcomes, suggesting that the medication may have helped mitigate elevated risk factors

Medication Dose: The current dose might not be the optimal or maximum tolerated dose needed to continue driving weight loss

The underlying reason is that, in the case of parenteral presentations, the effective doses of GLT-1 receptor agonists necessary for weight control are greater than those needed for glycemic control

Depressive symptoms, social support, and lipid profile in healthy middle-aged women Psychosom Med 1997

Finan B